Lung Cancer in MENA: Clinical and Research Initiatives
Internationally respect oncologists with deep expertise in lung cancer in the Middle East discuss, in Arabic, the role of smoking in lung cancer as well as how new targeted therapies and immunotherapi...
22 Joulu 202327min
IASLC Chronic Toxicity From Targeted Therapy
IASLC Chronic Toxicity From Targeted Therapy by IASLC
19 Joulu 202355min
LCC in Korean: Managing EGFR+ NSCLC
Lung cancer experts in Korea discuss the unique challenges they face when treating patients with lung cancer with EGFR and non-small cell lung cancer.
15 Joulu 202350min
New Options for Initial Treatment of EGFR Mutant NSCLC
In this episode, host Dr. Stephen Liu leads a discussion on the current first-line treatment options for EGFR-mutant non-small cell lung cancer, including how new data from FLAURA2 and MARIPOSA may in...
12 Joulu 202345min
Research from NACLC: Nutrition as Medicine and Lung Cancer Screening
IASLC Lung Cancer Considered host Dr. Narjust Florez interviews two researchers presenting at the North America Conference on Lung Cancer: Dr. Carolyn Presley is an Associate Professor in the Divisio...
8 Joulu 202343min
FDA Approval: Repotrectinib, a ROS1 and NTRK inhibitor
Lung Cancer Considered host Dr. Stephen Liu moderates a discussion on the November 15, 2023, US FDA approval of repotrectinib for advanced NSCLC with a ROS1 gene fusion based on the single-arm, multi-...
30 Marras 202337min
FDA Approval: Perioperative Pembrolizumab and KEYNOTE 671
Host Dr. Narjust Florez leads a discussion about the data from the KEYNOTE 671 trial, presented at ASCO 2023 and ESMO 2023, that led to the first approval of the combination of pembrolizumab plus che...
28 Marras 202345min
It's time to talk about sexual health and lung cancer!
Sexual health of patients with lung cancer is poorly understood, highly prevalent, and not frequently discussed. However, sexual concerns are common in people with lung cancer, with many receiving ver...
28 Marras 202339min
